Singapore set to take laboratory deal to Phase II

Singapore’s antitrust enforcer has said it will take an in-depth look into a potential merger between pathology companies Innovative Diagnostics and Quest Laboratories unless they address its concerns.


Get unlimited access to all Global Competition Review content